Andre A Neves
Overview
Explore the profile of Andre A Neves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bulat F, Hesse F, Attili B, Solanki C, Mendichovszky I, Aigbirhio F, et al.
Cancers (Basel)
. 2023 Mar;
15(5.
PMID: 36900353
There is an unmet clinical need for imaging agents capable of detecting early evidence of tumor cell death, since the timing, extent, and distribution of cell death in tumors following...
2.
Parle D, Bulat F, Fouad S, Zecchini H, Brindle K, Neves A, et al.
Bioconjug Chem
. 2022 Jul;
33(8):1467-1473.
PMID: 35876696
Methylcyclopropene (Cyoc)-tagged tetra-acetylated monosaccharides, and in particular mannosamine derivatives, are promising tools for medical imaging of cancer using metabolic oligosaccharide engineering and the extremely fast inverse electron-demand Diels-Alder bioorthogonal reaction....
3.
Szucs Z, Joseph J, Larkin T, Xie B, Bohndiek S, Brindle K, et al.
Breast Cancer Res
. 2021 Mar;
23(1):32.
PMID: 33722249
No abstract available.
4.
Szucs Z, Joseph J, Larkin T, Xie B, Bohndiek S, Brindle K, et al.
Breast Cancer Res
. 2021 Feb;
23(1):25.
PMID: 33596961
Background: Ductal carcinoma in situ (DCIS) is a non-invasive form of early breast cancer, with a poorly understood natural history of invasive transformation. Necrosis is a well-recognized adverse prognostic feature...
5.
Bulat F, Hesse F, Hu D, Ros S, Willminton-Holmes C, Xie B, et al.
EJNMMI Res
. 2020 Dec;
10(1):151.
PMID: 33296043
Introduction: Trialing novel cancer therapies in the clinic would benefit from imaging agents that can detect early evidence of treatment response. The timing, extent and distribution of cell death in...
6.
Lim A, Neves A, Lam Shang Leen S, Lao-Sirieix P, Bird-Lieberman E, Singh N, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32708812
Cervical screening in low-resource settings remains an unmet need. Lectins are naturally occurring sugar-binding glycoproteins whose binding patterns change as cancer develops. Lectins discriminate between dysplasia and normal tissue in...
7.
Nelson A, Phipps R, Crane G, Venanzi N, Lockley W, Tredwell M, et al.
J Labelled Comp Radiopharm
. 2020 Jul;
:608-617.
PMID: 32678462
No abstract available.
8.
Lee B, Sun S, Jimenez-Moreno E, Neves A, Bernardes G
Bioorg Med Chem
. 2018 Feb;
26(11):3060-3064.
PMID: 29482952
Site-selective protein modification strategies can be used to insert non-natural functional groups into protein structures. Herein, we report on the use of the bis-electrophile 3-bromo-2-bromomethyl-1-propene as a reagent to introduce...
9.
Neves A, di Pietro M, ODonovan M, Waterhouse D, Bohndiek S, Brindle K, et al.
Endoscopy
. 2018 Jan;
50(6):618-625.
PMID: 29342490
Background And Study Aims: Endoscopic surveillance for Barrett's esophagus (BE) is limited by long procedure times and sampling error. Near-infrared (NIR) fluorescence imaging minimizes tissue autofluorescence and optical scattering. We...
10.
Freedy A, Matos M, Boutureira O, Corzana F, Guerreiro A, Akkapeddi P, et al.
J Am Chem Soc
. 2017 Dec;
139(50):18365-18375.
PMID: 29206031
Chemical modification of proteins is essential for a variety of important diagnostic and therapeutic applications. Many strategies developed to date lack chemo- and regioselectivity as well as result in non-native...